Christopher Dandoy
Children's Hospital Medical Center, Cincinnati
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher Dandoy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07635056 · Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory NeuroblastomaChildren's Hospital Medical Center, Cincinnati · recruiting · Neuroblastoma · principal investigator
- Ph2NCT05579639 · Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell TransplantChildren's Hospital Medical Center, Cincinnati · terminated · Allogeneic Stem Cell Transplantation · principal investigator
- N/ANCT04549038 · Time Restricted Nutrition in Pediatric Stem Cell Transplant RecipientsChildren's Hospital Medical Center, Cincinnati · completed · Hematopoietic Stem Cell Transplant · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitolUH3DE030401 · NIDCR · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2022 to 2025 · $518,153 awarded in 2025Same name and institution; not confirmed by an ID
- The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell TransplantR13HL173950 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2024 · $22,000 awarded in 2024Same name and institution; not confirmed by an ID
- Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized, multicenter, double-blind, placebo-controlled study evaluating twice daily oral xylitolUG3DE030401 · NIDCR · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2021 · $490,242 awarded in 2021Grant number is on one of their registry trials
- Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in PediatricsR21CA223503 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2018 to 2019 · $167,725 awarded in 2019Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in neuroblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:30 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed